Lower incidence of liver graft rejection in patients on diltiazem plus cyclosporine therapy

Transplant Proc. 1998 Jun;30(4):1437-8. doi: 10.1016/s0041-1345(98)00305-4.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Calcium Channel Blockers / therapeutic use*
  • Child
  • Cyclosporine / blood
  • Cyclosporine / therapeutic use*
  • Diltiazem / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Graft Rejection / epidemiology*
  • Graft Rejection / prevention & control
  • Humans
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / therapeutic use*
  • Incidence
  • Liver Transplantation / immunology*
  • Male
  • Middle Aged
  • Muromonab-CD3 / therapeutic use
  • Retrospective Studies

Substances

  • Calcium Channel Blockers
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Cyclosporine
  • Diltiazem